Mild myopathy is associated with COMP but not MATN3 mutations in mouse models of genetic skeletal diseases

Katarzyna A Piróg1, Yoshihisa Katakura, Aleksandr Mironov

  • 1Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Plos One
|December 7, 2013
PubMed

Insights

Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED) mouse models reveal genotype-specific muscle and tendon pathology, not dwarfism, causes limb weakness in these skeletal disorders.

Area of Science:

  • Skeletal biology
  • Connective tissue disorders
  • Myopathology

Background:

  • Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED) are skeletal dysplasias linked to mutations in COMP, matrilin-3, or collagen IX.
  • These conditions typically present with short-limbed dwarfism and premature osteoarthritis, but recent findings suggest associated muscle weakness.

Purpose of the Study:

  • To investigate the underlying causes of muscle weakness in PSACH and MED by analyzing specific mouse models.
  • To determine if short-limbed dwarfism or specific genetic mutations contribute to muscle pathology in these skeletal disorders.

Main Methods:

  • Comparative analysis of two mouse models: ΔD469 T3-COMP (PSACH) and V194D matrilin-3 (MED).
  • Grip strength testing to assess muscle function.
  • Histological examination of muscle and tendon tissues to identify pathological changes.

Main Results:

  • T3-COMP mice exhibited reduced grip strength compared to wild-type littermates, while V194D mice showed no significant difference.
  • T3-COMP muscles displayed increased centronuclear fibers at the myotendinous junction.
  • T3-COMP tendons were laxer and had thicker collagen fibers, indicating tendon pathology; matrilin-3 mutant tissues were normal.

Conclusions:

  • Limb weakness in PSACH/MED is attributable to specific muscle and tendon pathologies, not short-limbed dwarfism itself.
  • The observed myopathy is genotype-specific, highlighting the importance of genetic background in disease manifestation.
  • This study enhances understanding of PSACH/MED disease progression and aids in recognizing neuromuscular symptoms as potential differential diagnoses.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
29
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K